SG11201800675PA - Composition containing cyclic dipeptide and sweetening agent - Google Patents
Composition containing cyclic dipeptide and sweetening agentInfo
- Publication number
- SG11201800675PA SG11201800675PA SG11201800675PA SG11201800675PA SG11201800675PA SG 11201800675P A SG11201800675P A SG 11201800675PA SG 11201800675P A SG11201800675P A SG 11201800675PA SG 11201800675P A SG11201800675P A SG 11201800675PA SG 11201800675P A SG11201800675P A SG 11201800675PA
- Authority
- SG
- Singapore
- Prior art keywords
- composition containing
- sweetening agent
- containing cyclic
- cyclic dipeptide
- dipeptide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Seasonings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015147652 | 2015-07-27 | ||
PCT/JP2016/071817 WO2017018404A1 (ja) | 2015-07-27 | 2016-07-26 | 環状ジペプチド及び甘味料を含有する組成物 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201800675PA true SG11201800675PA (en) | 2018-02-27 |
Family
ID=57885678
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201912392SA SG10201912392SA (en) | 2015-07-27 | 2016-07-26 | Composition containing cyclic dipeptide and sweetening agent |
SG11201800675PA SG11201800675PA (en) | 2015-07-27 | 2016-07-26 | Composition containing cyclic dipeptide and sweetening agent |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201912392SA SG10201912392SA (en) | 2015-07-27 | 2016-07-26 | Composition containing cyclic dipeptide and sweetening agent |
Country Status (10)
Country | Link |
---|---|
US (1) | US11219663B2 (ja) |
EP (1) | EP3329928A4 (ja) |
JP (1) | JP6777632B2 (ja) |
KR (1) | KR20180030915A (ja) |
CN (1) | CN107847545B (ja) |
AU (1) | AU2016299590B2 (ja) |
HK (1) | HK1250630A1 (ja) |
SG (2) | SG10201912392SA (ja) |
TW (1) | TWI744240B (ja) |
WO (1) | WO2017018404A1 (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020218381A1 (ja) * | 2019-04-26 | 2020-10-29 | サントリーホールディングス株式会社 | Glp-1分泌促進用組成物 |
JPWO2020218382A1 (ja) * | 2019-04-26 | 2020-10-29 | ||
SG11202111838SA (en) | 2019-04-26 | 2021-11-29 | Suntory Holdings Ltd | Glp-1 secretion-promoting composition |
CN113747921A (zh) * | 2019-04-26 | 2021-12-03 | 三得利控股株式会社 | Glp-1分泌促进用组合物 |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5426347A (en) * | 1977-07-27 | 1979-02-27 | Sugiyama Sangyo Kagaku Kenk | Extracting of soy bean protein |
IE65900B1 (en) | 1988-10-15 | 1995-11-29 | Satake Eng Co Ltd | Apparatus for evaluating quality of raw coffee beans |
AU784422B2 (en) * | 2000-02-01 | 2006-03-30 | Stevia Aps | A substance for the use in a dietary supplementation or for the preparation of a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome |
US20030059514A1 (en) * | 2001-09-10 | 2003-03-27 | Villagran Francisco Valentino | Compositions comprising soy protein and processes of their preparation |
JP2003252896A (ja) | 2002-02-26 | 2003-09-10 | Toyohashi University Of Technology | 高温高圧水を用いた環状ペプチドの合成方法 |
US20070128687A1 (en) | 2003-11-28 | 2007-06-07 | Hajime Ikeda | Process for producing dipeptides |
JP4605631B2 (ja) | 2004-01-23 | 2011-01-05 | カルピス株式会社 | アンジオテンシン変換酵素阻害剤 |
KR101175608B1 (ko) | 2004-12-08 | 2012-08-22 | 다카사고 고료 고교 가부시키가이샤 | 효소 처리 차류 추출액, 효소 처리 차류 내츄럴 아로마 및 효소 처리 차류 내츄럴 아로마 농축 추출액의 제조방법, 및 이에 의해 수득되는 효소 처리 차류 추출액, 효소 처리 차류 내츄럴 아로마 및 효소 처리 차류 내츄럴 아로마 농축추출액 |
WO2006116814A1 (en) * | 2005-05-02 | 2006-11-09 | Vanadis Bioscience Ltd | Composition and uses thereof |
US8945652B2 (en) * | 2005-11-23 | 2015-02-03 | The Coca-Cola Company | High-potency sweetener for weight management and compositions sweetened therewith |
US20080107787A1 (en) * | 2006-11-02 | 2008-05-08 | The Coca-Cola Company | Anti-Diabetic Composition with High-Potency Sweetener |
JP2010138143A (ja) * | 2008-12-15 | 2010-06-24 | Hokkaido Univ | Glp−1分泌促進剤 |
JP5576653B2 (ja) | 2008-12-26 | 2014-08-20 | サントリー食品インターナショナル株式会社 | 環状ジペプチド含有飲料 |
CN101461441A (zh) | 2008-12-29 | 2009-06-24 | 浙江工商大学 | 茶叶蛋白的双酶提取法 |
CN102361560A (zh) * | 2008-12-31 | 2012-02-22 | 索莱有限责任公司 | 具有提高的cck释放能力的蛋白质水解产物组合物 |
US9901551B2 (en) * | 2009-04-20 | 2018-02-27 | Ambra Bioscience Llc | Chemosensory receptor ligand-based therapies |
SG178211A1 (en) | 2009-12-25 | 2012-03-29 | Suntory Holdings Ltd | Extracts and beverages containing 2, 5-piperazinedione, 3, 6-bis (phenylmethyl) -, (3s, 6s) - |
AU2010334164B2 (en) | 2009-12-25 | 2014-09-11 | Suntory Beverage & Food Asia Pte. Ltd. | Learning motivation improvers |
JP4901950B2 (ja) | 2009-12-25 | 2012-03-21 | サントリーホールディングス株式会社 | 2,5−ピペラジンジオン,3,6−ビス(フェニルメチル)−,(3s,6s)−を含有する酸性飲食品 |
EA023932B1 (ru) | 2010-09-07 | 2016-07-29 | Ампио Фармасьютикалз, Инк. | Лечение заболеваний, связанных с гиперпроницаемостью сосудов |
CN104220875A (zh) * | 2010-10-19 | 2014-12-17 | 埃尔舍利克斯治疗公司 | 基于化学感应受体配体的治疗 |
CN103314000B (zh) * | 2010-11-19 | 2018-07-27 | 嘉吉公司 | 使用具有大孔中性吸附树脂的吸附-脱附色谱用于富集衍生自甜叶菊的糖苷组合物中的新蛇菊苷b和/或新蛇菊苷d的方法 |
WO2012111820A1 (ja) | 2011-02-17 | 2012-08-23 | サントリーホールディングス株式会社 | 茶飲料用原料の製造方法 |
EP4012041A1 (en) | 2012-05-22 | 2022-06-15 | PureCircle SDN BHD | High-purity steviol glycosides |
JP5456876B1 (ja) | 2012-12-25 | 2014-04-02 | ゼライス株式会社 | 環状ジペプチドの製造方法 |
WO2014200000A1 (ja) * | 2013-06-10 | 2014-12-18 | サントリーホールディングス株式会社 | ジケトピペラジンを含有する植物エキス及びその製造方法 |
CN104817615A (zh) | 2014-01-30 | 2015-08-05 | 陈光健 | 寡肽cd05及其制备方法和应用 |
WO2015194035A1 (ja) * | 2014-06-20 | 2015-12-23 | サントリーホールディングス株式会社 | 環状ジペプチド含有組成物 |
AU2014397560A1 (en) | 2014-06-20 | 2017-01-05 | Suntory Holdings Limited | Composition with high content of cyclic dipeptide |
CA2904493A1 (en) | 2014-06-20 | 2015-12-20 | Toshihide Suzuki | Uric acid-lowering agent |
WO2015194447A1 (ja) | 2014-06-20 | 2015-12-23 | サントリーホールディングス株式会社 | 糖代謝改善剤 |
-
2016
- 2016-07-26 EP EP16830509.2A patent/EP3329928A4/en not_active Withdrawn
- 2016-07-26 AU AU2016299590A patent/AU2016299590B2/en not_active Expired - Fee Related
- 2016-07-26 JP JP2017530873A patent/JP6777632B2/ja active Active
- 2016-07-26 US US15/746,834 patent/US11219663B2/en active Active
- 2016-07-26 SG SG10201912392SA patent/SG10201912392SA/en unknown
- 2016-07-26 WO PCT/JP2016/071817 patent/WO2017018404A1/ja active Application Filing
- 2016-07-26 SG SG11201800675PA patent/SG11201800675PA/en unknown
- 2016-07-26 CN CN201680043982.XA patent/CN107847545B/zh active Active
- 2016-07-26 KR KR1020187005678A patent/KR20180030915A/ko not_active Application Discontinuation
- 2016-07-27 TW TW105123766A patent/TWI744240B/zh active
-
2018
- 2018-08-03 HK HK18110016.9A patent/HK1250630A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
WO2017018404A1 (ja) | 2017-02-02 |
HK1250630A1 (zh) | 2019-01-11 |
AU2016299590B2 (en) | 2022-09-01 |
US20180214508A1 (en) | 2018-08-02 |
KR20180030915A (ko) | 2018-03-26 |
CN107847545B (zh) | 2022-01-04 |
AU2016299590A1 (en) | 2018-02-22 |
TWI744240B (zh) | 2021-11-01 |
TW201717988A (zh) | 2017-06-01 |
US11219663B2 (en) | 2022-01-11 |
EP3329928A4 (en) | 2019-05-01 |
EP3329928A1 (en) | 2018-06-06 |
SG10201912392SA (en) | 2020-02-27 |
CN107847545A (zh) | 2018-03-27 |
JP6777632B2 (ja) | 2020-10-28 |
JPWO2017018404A1 (ja) | 2018-05-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL262321A (en) | Preparations and methods for selective protein expression | |
ZA201706256B (en) | Hemostatic composition and hemostatic device (variants) | |
PL3228648T3 (pl) | Kopoliwęglan i zawierające go kompozycje | |
HK1250925A1 (zh) | 包含依魯替尼的組合物 | |
PL3269257T3 (pl) | Kompozycja słodzika i żywność ją zawierająca | |
PL3048127T3 (pl) | Kopoliwęglan i zawierająca go kompozycja | |
HK1231330A1 (zh) | 高含有環狀二肽的組合物 | |
PL3067379T3 (pl) | Kopoliwęglan i zawierająca go kompozycja | |
HK1254978A1 (zh) | 含萊鮑迪甙d的甜味劑組合物 | |
HK1250630A1 (zh) | 含有環狀二肽及甜味劑的組合物 | |
IL284792A (en) | Peptide derivative - DEPDC1 and a component containing it | |
HK1258374A1 (zh) | 止血組合物和使用止血組合物的止血方法 | |
HK1250915A1 (zh) | 組合物和其用途 | |
PL3050908T3 (pl) | Kopoliwęglan i zawierająca go kompozycja | |
HK1250726A1 (zh) | 含有氨基酸及環狀二肽的組合物 | |
HK1247220A1 (zh) | 環狀甘丙肽類似物及其用途 | |
IL251236B (en) | Preparations containing glycosaminoglycans and proteins and their uses | |
IL250215A0 (en) | A peptide derived from cdca1 and a component containing it | |
PL3307080T3 (pl) | Środek słodzący oraz jego zastosowanie | |
IL250235A0 (en) | A peptide derived from urlc10 and a component containing it | |
PL3050909T3 (pl) | Kopoliwęglan i obejmująca go kompozycja | |
GB201504273D0 (en) | Overhood seal and use thereof |